1. Home
  2. IMAX vs HTFL Comparison

IMAX vs HTFL Comparison

Compare IMAX & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Imax Corporation

IMAX

Imax Corporation

HOLD

Current Price

$35.78

Market Cap

2.1B

Sector

N/A

ML Signal

HOLD

HTFL

Heartflow Inc.

HOLD

Current Price

$29.96

Market Cap

2.2B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMAX
HTFL
Founded
1967
2007
Country
Canada
United States
Employees
N/A
N/A
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.2B
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
IMAX
HTFL
Price
$35.78
$29.96
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
10
5
Target Price
$44.50
$38.20
AVG Volume (30 Days)
1.1M
1.0M
Earning Date
04-30-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
31.25
N/A
EPS
0.07
N/A
Revenue
$410,212,000.00
N/A
Revenue This Year
$9.79
$27.66
Revenue Next Year
$7.51
$23.55
P/E Ratio
$511.86
N/A
Revenue Growth
16.47
N/A
52 Week Low
$24.20
$20.13
52 Week High
$43.16
$41.22

Technical Indicators

Market Signals
Indicator
IMAX
HTFL
Relative Strength Index (RSI) 42.24 56.14
Support Level $33.64 $28.86
Resistance Level $37.52 $32.81
Average True Range (ATR) 1.50 1.61
MACD -0.07 -0.29
Stochastic Oscillator 36.77 39.89

Price Performance

Historical Comparison
IMAX
HTFL

About IMAX Imax Corporation

Imax Corp is a technology platform for entertainment and events. Through its proprietary software, auditorium architecture, patented intellectual property, and specialized equipment, IMAX offers end-to-end solution to create superior, immersive content experiences for which the IMAX brand is globally renowned. The Company has two reportable segments being Content Solutions and Technology Products and Services. The Company leverages its proprietary technology and engineering in all aspects of its business, which principally consists of the IMAX film remastering and the sale or lease of premium IMAX theater systems.

About HTFL Heartflow Inc.

HeartFlow Inc is a commercial-stage medical technology company that has pioneered the use of software and AI to deliver a non-invasive solution for diagnosing and managing coronary artery disease CAD. The company operates and manages its business as one reportable and operating segment, which is the business of non-invasive coronary artery disease detection solutions. Geographically, it operates in United States, United Kingdom, Japan, and Rest of Europe, of which it derives maximum revenue from United States.

Share on Social Networks: